CN107582834A - A kind of Chinese medicine composition for treating empty asthma - Google Patents
A kind of Chinese medicine composition for treating empty asthma Download PDFInfo
- Publication number
- CN107582834A CN107582834A CN201710851039.8A CN201710851039A CN107582834A CN 107582834 A CN107582834 A CN 107582834A CN 201710851039 A CN201710851039 A CN 201710851039A CN 107582834 A CN107582834 A CN 107582834A
- Authority
- CN
- China
- Prior art keywords
- asthma
- chinese
- chinese medicine
- fruit
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The present invention relates to the Chinese medicine composition of the empty asthma for the treatment of, can effectively solve the problems, such as the medication of empty asthma, and its technical scheme solved is that the Chinese medicine composition is made up of the material medicine of following weight meter：60~90g of radix rehmanniae recen, 60~90g of Chinese yam, 30~60g of dogwood fruit, 30~60g of the root bark of tree peony, 30~60g of Poria cocos, 30~60g of rhizoma alismatis, 30~60g of the fruit of Chinese magnoliavine, 50~100g of the tuber of dwarf lilyturf, 60~120g of Radix Codonopsis, the component of the present composition uses natural Chinese medicine material, its preparation is easy, raw material supply is abundant, economic security, verify by clinic application, its is evident in efficacy, do not occur toxic side effect, be the innovation on the empty asthma medicine for the treatment of.
Description
Technical field
The present invention relates to field of medicaments, particularly a kind of Chinese medicine composition for treating empty asthma.
Background technology
Western medicine thinks, bronchial astehma（bronchial asthma）It is by various kinds of cell (particularly mast cell, thermophilic
Eosinophil and T lymphocytes etc.) and cellular component participate in chronic inflammatory airway disease, such a inflammation in susceptible person
Can cause panting for recurrent exerbation, shortness of breath, it is uncomfortable in chest and（Or）The symptoms such as cough, occur or aggravate, air flue at night and morning more
A variety of stimulating factor reactivity are increased, but can be alleviated voluntarily or through controlling.Severe patient can developing over days to several weeks or in one day
For several times, patient is very painful for breaking-out.With the passing of time breaking-out can cause the vitals such as heart and brain that serious change occurs because of anoxic.
Asthma is one of chronic refractory disease of serious threat human physical and mental health, and its incidence of disease and case fatality rate are in
Ascendant trend year by year, the illness rate of China's asthma are up to 0.5%~5%, it is estimated that the whole nation there are about more than 1,000 ten thousand asthmatic patient.
The hazards of asthma include host factor（Inherent cause）In terms of environmental factor two, but most of asthmatic patient category
In allergic constitution.The clinical manifestation of asthma is divided into acute attack stage, chronic sustained phase and clinical relieving period, acute attack, treatment
May be fatal when not in time.Western medical treatment asthma mainly based on glucocorticoid medicine, although having certain curative effect, is grown
Phase takes, and side effects of pharmaceutical drugs can produce larger injury to human body, easily trigger other complication.Therefore, asthma drug is treated
The problem of improvement on thing is current urgent need to resolve.
The content of the invention
For the above situation, to solve the defect of prior art, the purpose of the present invention, which is just to provide, a kind of treats empty breathe heavily
Chinese medicine composition, can effectively solve the problems, such as the medication of empty asthma.
The traditional Chinese medical science thinks, the cause of disease not outer inside and outside two of asthma because：It is outer because heresy etc. when experiencing the six external factors which cause diseases, internal cause then by diet not
Section, feelings will are hindered, sexual intercourse overstrain, or natural endowment is weak, after serious disease prolonged illness etc..Its interpretation of the cause, onset and process of an illness also not outer positive deficiency of vital energy and excess of pathogen two
End.Three dirty deficiency of lung spleen kidney, mutually and mutually because disease, it is the positive deficiency of vital energy of meaning, is more common in the paracmasis；Six external factors which cause diseases diseases caused by external factors, it is strongly fragrant in phlegm and retained fluid fire-evil
And other various pessimal stimulations, it is meaning excess of pathogen, is more common in stage of attack.Void asthma, symptoms include asthma of losing heart are inverse, and rest asthma is light, dynamic then breathe heavily
Play, palpitaition phlegm is few, and rapid pulse is powerless, or with dizziness and tinnitus, the person of quenching one's thirst.Accordingly, the technical scheme that the present invention solves is the Chinese medicine
Composition is made up of the material medicine of following weight meter：60~90g of radix rehmanniae recen, 60~90g of Chinese yam, 30~60g of dogwood fruit, pellet
30~60g of skin, 30~60g of Poria cocos, 30~60g of rhizoma alismatis, 30~60g of the fruit of Chinese magnoliavine, 50~100g of the tuber of dwarf lilyturf, 60~120g of Radix Codonopsis.
The component of the present composition uses natural Chinese medicine material, and it is prepared, and easy, raw material supply is abundant, economic peace
Entirely.It follows the prescriptions principle of the traditional Chinese medical science, verifies by clinic application, and its is evident in efficacy, does not occur toxic side effect, is that treatment is empty
Breathe heavily the innovation on medicine.
Embodiment
The embodiment of the present invention is described in further detail with reference to embodiments.
Embodiment 1
The present invention in the specific implementation, is made up of the material medicine of following weight meter：Radix rehmanniae recen 60g, Chinese yam 60g, dogwood fruit
30g, root bark of tree peony 30g, Poria cocos 30g, rhizoma alismatis 30g, fruit of Chinese magnoliavine 30g, tuber of dwarf lilyturf 50g, Radix Codonopsis 60g.
Embodiment 2
The present invention in the specific implementation, is made up of the material medicine of following weight meter：Radix rehmanniae recen 90g, Chinese yam 90g, dogwood fruit
60g, root bark of tree peony 60g, Poria cocos 30g, rhizoma alismatis 30g, fruit of Chinese magnoliavine 60g, tuber of dwarf lilyturf 60g, Radix Codonopsis 80g.
Embodiment 3
The present invention in the specific implementation, is made up of the material medicine of following weight meter：Radix rehmanniae recen 75g, Chinese yam 60g, dogwood fruit
30g, root bark of tree peony 45g, Poria cocos 50g, rhizoma alismatis 50g, fruit of Chinese magnoliavine 30g, tuber of dwarf lilyturf 60g, Radix Codonopsis 90g.
Embodiment 4
The present invention in the specific implementation, can also be made up of the material medicine of following weight meter：Radix rehmanniae recen 70g, Chinese yam 75g, mountain cornel
Meat 45g, root bark of tree peony 45g, Poria cocos 45g, rhizoma alismatis 45g, fruit of Chinese magnoliavine 45g, tuber of dwarf lilyturf 75g, Radix Codonopsis 100g.
Various preparations can be made according to a conventional method for Chinese medicine composition of the present invention, and below by taking pill as an example, specific method is as follows：
Weigh the said medicine of constant weight in proportion first, then after putting it into drying baker processing being dried, with electronic crushing
All medicines are ground into fine powder by machine, sieving, collect fine powder, and coarse powder is repeated to crush and sieve again, repeated, until will
All medicines break into fine powder, mix standby.Add refined honey 80g that big honeyed bolus is made per 100g powder, the weight 9g per ball.
In prescription of the present invention, prepared rhizome of rehmannia, enriching yin and nourishing kidney, life essence-filling, marrow-benefitting；Dogwood fruit mends nourishing liver and kidney, and can puckery essence；Chinese yam is mended
Beneficial spleen is cloudy, also can controlling nocturnal emission with astringent drugs, three medicine phases match somebody with somebody, nourish liver and spleen kidney, be referred to as " three mend ".Compatibility rhizoma alismatis dampness removing let out it is turbid, and anti-prepared rhizome of rehmannia it
It is evil to grow greasy love；Moutan bark lets out clearly mutually fire, and the temperature of FRUCTUS CORNI PREPARATA is puckery；The light spleen that oozes of Poria cocos is wet, and helps the strong fortune of Chinese yam.Three medicines are
" three rush down ", excreting dampness is turbid, clearind deficient heat, and putting down it, to take stopgap measures, Six-element shares victory partially, and three, which mend three, rushes down, treating a disease by looking into both its root cause and symptoms.The sweet temperature of Radix Codonopsis, benefit member
Gas, tonifying lung gas, born fluid；The sweet cold replenishing the vital essence and removing heat of the tuber of dwarf lilyturf, moistening lung and production of body fluid, ginseng, the tuber of dwarf lilyturf share, then the work(benefit of supplementing qi and nourishing yin
It is evident；Fruit of Chinese magnoliavine acid temperature, astringes the lung to stop cough, and three medicines share, and one, which mends a profit one, holds back, the power multiplication of supplementing qi and nourishing yin.It can be seen that present invention combination
Compatibility of drugs in thing is precise and appropriate, is complemented each other using, and has synergy, plays nourishing lung and kidney, QI invigorating calming heart, yin-nourishing life altogether
The work(in Tianjin, for treating empty asthma, symptoms include asthma of losing heart is inverse, and rest asthma is light, and dynamic then asthma play, palpitaition phlegm is few, and rapid pulse is powerless, or with head
Dizzy tinnitus, the person of quenching one's thirst.Also the person that belongs to deficiency of qi and yin such as catabasis of bronchitis asthma, pulmonary emphysema, pulmonary heart disease can be treated, lung kidney is same
Adjust, mutual generation between metal and water, controlled from this.
Above-mentioned component science, reasonable compatibility, support mutually, there is nourishing lung and kidney, QI invigorating calming heart, nourishing Yin and promoting production of body fluid and other effects,
Effective for the empty asthma for the treatment of, good effect, drug safety, and obtain fully proving through clinical data, relevant clinical data is as follows：
Clinical data
First, general data：Chinese medicine composition of the present invention is applied to clinical observation case 40, wherein man 24, female 16, year
One full year of life in age 14~65.
2nd, diagnostic criteria
L, often there are the premonitory symptoms such as sneeze, cough before breaking out, or night breaks out；Wheezing between larynx during breaking-out, expiratory dyspnea,
Expectoration is not well, very can not then lie down, have the fidgets etc.；
2nd, often because of climate flip, suffer from cold, or the factor such as some allergins of contact induces；Part can have infancy eczema history, or
Family's allergies；
3rd, heart and lung auscultation：Two lungs are abound with wheezing sound, expiratory flow retard, or news and bubble, increased heart rate；
4th, bronchial astehma, blood leukocytes sum is normal, and eosinophil can increase, suspicious allergen skin test Chang Chengyang
Property；During with pulmonary infection, blood leukocytes sum and neutrophil leucocyte can increase.
3rd, Standards of Chinese Medical Syndrome Differentiation
1st, Asthma in Remission Stage, asthma of losing heart is inverse, and rest asthma is light, and dynamic then asthma play, palpitaition phlegm is few, and rapid pulse is powerless, or with dizziness and tinnitus,
Soreness and weakness of waist and knees, quench one's thirst；
2nd, without rough sound pitch, phlegm Huang stiff, flushing is irritated, and bitter taste tongue is done, the obvious thermal image such as red rapid pulse of tongue, also without the thin amount of expectoration
More, aversion to cold is cold, floating and tense pulse effectively wait it is obvious cold as.
4th, therapeutic scheme：During clinical practice, clothes are chewed before meals, every time 1 ball, 2 times a day, 10 are a course for the treatment of.
5th, criterion of therapeutical effect
1st, clinical cure：Asthma is calmed down, and the lung wheezing sound of auscultation two disappears；
2nd, it is effective：Asthma mitigates, and wheezing sound is occasionally heard in auscultation；
3rd, it is invalid：Asthma attack symptom is without improvement.
6th, therapeutic effect：In the clinical observation case, 9-15 courses for the treatment of of taking medicine, clinical cure 17, effective 20, nothing
Effect 3.Obvious effective rate 92.5%, adverse drug reaction does not occur during treatment.
7th, model case
Case 1：Zhu, man, 63 years old.Shortness of breath uncomfortable in chest is coughed to be aggravated 10 years into the winter.Just disease is only coughed uncomfortable in chest, rear gradually to aggravate,
Asthma in nearly 2 years is very, dynamic then aggravate, and to the cold and enters winter aggravation, very can not then take action.Cold cough is met to spit, it is dynamic then breathe heavily very.
Long-term use of Chinese and western drugses DeGrain.Cough is spat not very heavy when medical, and only then shortness of breath is uncomfortable in chest for activity, auscultation do not hear and
Wheezing sound, diet spirit, pulse condition sinks weak.It is dialectical to be breathed heavily to be empty, take medicine pill prepared by the Chinese medicine composition of the present invention
After 10 courses for the treatment of, feel that asthma takes a turn for the better, breathing is smooth, is also not very breathed heavily after activity；Continue to take 5 courses for the treatment of and consolidate curative effect, half a year
After pay a return visit, the state of an illness is not reaccessed, clinical cure.
Case 2：Zhang, man, 56 years old.Cough and asthma 13 years.Patient is before 13 years because being fully recovered after cough after common cold hospitalization first quarter moon
Discharge, hereafter just occurs to pant repeatedly, though without big breaking-out, asthma uncomfortable in chest all the time, band foam of spitting, entering winter exacerbation every year need to be in hospital
It can alleviate after treatment, summer is slightly light.Once the equal unobvious of various regions therapeutic effect were hurried to, often take aminophylline and various sprays
Deng antiasthmatics.It is short of breath when medical, cough and asthma, tells the dilute phlegm of white and tell unfavorable, there are wheezing sound, tongue nature in the right back of auscultation
Light red, tongue is coarse in vain, and pulse condition delays weak.Dialectical to be breathed heavily to be empty, the Chinese medicine for successively persistently taking the Chinese medicine composition preparation of the present invention is close
15 courses for the treatment of of pill, all diseases disappear, clinical cure.Paid a return visit after March, the state of an illness is not again repeatedly.
8th, conclusion
Component science of the present invention, abundant raw material is cheap, reasonable compatibility, supports mutually, has a nourishing lung and kidney, QI invigorating calming heart,
Nourishing Yin and promoting production of body fluid and other effects, for curing mainly empty asthma, symptoms include asthma of losing heart is inverse, and rest asthma is light, and dynamic then asthma play, palpitaition phlegm is few, and rapid pulse is powerless,
Or with dizziness and tinnitus, the person of quenching one's thirst.The person that belongs to deficiency of qi and yin such as catabasis of bronchitis asthma, pulmonary emphysema, pulmonary heart disease can be treated.It is real
Proof is trampled, Chinese medicine composition clinical efficacy of the present invention is notable, can reach the purpose of the empty asthma recurrent exerbation of effectively control, and nontoxic
Side effect, it is safe, there is actual clinical meaning.
Claims (5)
1. a kind of Chinese medicine composition for treating empty asthma, it is characterised in that the Chinese medicine composition is by the bulk drug of following weight meter
Thing is made：60~90g of radix rehmanniae recen, 60~90g of Chinese yam, 30~60g of dogwood fruit, 30~60g of the root bark of tree peony, 30~60g of Poria cocos, rhizoma alismatis 30
~60g, 30~60g of the fruit of Chinese magnoliavine, 50~100g of the tuber of dwarf lilyturf, 60~120g of Radix Codonopsis.
2. the Chinese medicine composition of the empty asthma for the treatment of according to claim 1, it is characterised in that by the bulk drug of following weight meter
Thing is made：Radix rehmanniae recen 60g, Chinese yam 60g, dogwood fruit 30g, root bark of tree peony 30g, Poria cocos 30g, rhizoma alismatis 30g, fruit of Chinese magnoliavine 30g, tuber of dwarf lilyturf 50g,
Radix Codonopsis 60g.
3. the Chinese medicine composition of the empty asthma for the treatment of according to claim 1, it is characterised in that by the bulk drug of following weight meter
Thing is made：Radix rehmanniae recen 90g, Chinese yam 90g, dogwood fruit 60g, root bark of tree peony 60g, Poria cocos 30g, rhizoma alismatis 30g, fruit of Chinese magnoliavine 60g, tuber of dwarf lilyturf 60g,
Radix Codonopsis 80g.
4. the Chinese medicine composition of the empty asthma for the treatment of according to claim 1, it is characterised in that by the bulk drug of following weight meter
Thing is made：Radix rehmanniae recen 75g, Chinese yam 60g, dogwood fruit 30g, root bark of tree peony 45g, Poria cocos 50g, rhizoma alismatis 50g, fruit of Chinese magnoliavine 30g, tuber of dwarf lilyturf 60g,
Radix Codonopsis 90g.
5. the Chinese medicine composition of the empty asthma for the treatment of according to claim 1, it is characterised in that by the bulk drug of following weight meter
Thing is made：Radix rehmanniae recen 70g, Chinese yam 75g, dogwood fruit 45g, root bark of tree peony 45g, Poria cocos 45g, rhizoma alismatis 45g, fruit of Chinese magnoliavine 45g, tuber of dwarf lilyturf 75g,
Radix Codonopsis 100g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710851039.8A CN107582834A (en) | 2017-09-20 | 2017-09-20 | A kind of Chinese medicine composition for treating empty asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710851039.8A CN107582834A (en) | 2017-09-20 | 2017-09-20 | A kind of Chinese medicine composition for treating empty asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107582834A true CN107582834A (en) | 2018-01-16 |
Family
ID=61047899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710851039.8A Pending CN107582834A (en) | 2017-09-20 | 2017-09-20 | A kind of Chinese medicine composition for treating empty asthma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107582834A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112402549A (en) * | 2020-11-26 | 2021-02-26 | 赵子荣 | Medicine for treating bronchial asthma |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1879797A (en) * | 2006-04-29 | 2006-12-20 | 金方义 | A Chinese proprietary medicine for mainly treating bronchitis and asthma and method for preparing same |
| CN105833034A (en) * | 2016-05-26 | 2016-08-10 | 张晓燕 | Traditional Chinese medicine composition |
| CN106563067A (en) * | 2016-11-04 | 2017-04-19 | 上海辰松新材料科技有限公司 | Anagex extract |
-
2017
- 2017-09-20 CN CN201710851039.8A patent/CN107582834A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1879797A (en) * | 2006-04-29 | 2006-12-20 | 金方义 | A Chinese proprietary medicine for mainly treating bronchitis and asthma and method for preparing same |
| CN105833034A (en) * | 2016-05-26 | 2016-08-10 | 张晓燕 | Traditional Chinese medicine composition |
| CN106563067A (en) * | 2016-11-04 | 2017-04-19 | 上海辰松新材料科技有限公司 | Anagex extract |
Non-Patent Citations (2)
| Title |
|---|
| 张树生等: "《中医临床必读》", 30 September 1999, 中国中医药出版社 * |
| 钟赣生: "《中药学》", 31 August 2016, 中国中医药出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112402549A (en) * | 2020-11-26 | 2021-02-26 | 赵子荣 | Medicine for treating bronchial asthma |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101780237A (en) | Traditional Chinese medicine composition for treating cough and preparation method thereof | |
| CN101693089B (en) | Traditional Chinese medicine compound for treating diseases of lung Qi obstruction and dyspnea chest discomfort and preparation method thereof | |
| CN101658631A (en) | Drug for treating chronic bronchitis and pulmonary emphysema | |
| CN101829293A (en) | Traditional Chinese medicine composite for treating cough disease and preparation method thereof | |
| CN101766804A (en) | Chinese herbal composite for epistaxis treatment and preparation method thereof | |
| CN106138360A (en) | A kind of Chinese medicine composition and preparation method thereof, application | |
| CN101829296B (en) | Traditional Chinese medicine combination for treating pulmonary atelectasis and preparation method thereof | |
| CN104940485A (en) | Traditional Chinese medicine composition for treating infantile asthma and preparation method thereof | |
| CN102512540B (en) | Chinese medicine composition for treating asthma | |
| CN101785846A (en) | Traditional Chinese medicine combination and preparation method for intestinal depression disease treatment | |
| CN101822814A (en) | Traditional Chinese medicine composition for treating lung failure and preparation method thereof | |
| CN107582834A (en) | A kind of Chinese medicine composition for treating empty asthma | |
| CN104288477A (en) | Traditional Chinese medicine preparation curing infantile asthma | |
| CN103263654A (en) | Medicine for treating lobar pneumonia and preparation method thereof | |
| CN106237056A (en) | A kind of Chinese medicine decoction treating chronic bronchitis | |
| CN105963501A (en) | Method for preparing traditional Chinese medicine composition for treating infantile asthma | |
| CN104758884A (en) | Traditional Chinese medicine composition for treating asthma | |
| CN107617091A (en) | A kind of Chinese medicine composition for treating cold asthma | |
| CN103083524A (en) | Traditional Chinese medicine granules used for treating chicken aspergillosis, and preparation method thereof | |
| CN107496745A (en) | A kind of Chinese medicine composition for treating heat asthma | |
| CN102284023A (en) | Chinese medicinal composition for treating asthma | |
| CN106511752A (en) | Traditional Chinese medicine composition for treating anxiety insomnia of young people | |
| CN105832885A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN104815143A (en) | Traditional Chinese medicine composition for promoting children asthma health, and preparation method thereof | |
| CN105362548A (en) | Traditional Chinese medicine for treating allergic asthma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180116 |
|
| RJ01 | Rejection of invention patent application after publication |